ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach

2025/05/01 by Lærke Rosenlund, Kasper Guldbrandsen, Lise Barlebo Ahlborn +40

paper · doi:10.1016/j.lungcan.2025.108528

crossref created 2025/04/06 · crossref issued 2025/05/01 · crossref published 2025/05/01 · crossref published-print 2025/05/01 · crossref deposited 2026/05/03 · crossref indexed 2026/08/05

Citations

• Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up